欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
我国生物医药产业共性技术供给不足的主要原因是：供给出现市场失灵和组织失灵,技术体系复杂导致供给困难,技术开发时间长、风险高.针对这些原因提出加强对策,包括：依托政府克服市场失灵现象,通过组织创新克服组织失灵现象,由生物医药产业园区的企业集群供给产业共性技术,对产业共性技术供给模式进行创新.
英文摘要：
Market failure and organizational failure in the supply,complex technical systems,and the long time and high risk of technology development,which are all the reasons for the insufficient supply of Chinese bio-pharmaceutical industrial generic technology.The countermeasures of strengthening bio-pharmaceutical industry and its supplied services are as follows：rely on government to overcome market failures; overcome organizational failures through organizational innovation; supply industrial generic technology by the enterprise cluster of liomedical industry park; innovate generic technology supply model.
同期刊论文项目
同项目期刊论文
期刊信息
位置：